Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Network Meta-analysis

INTRODUCTION: The present study aimed to evaluate the effects of glucagon-like peptide 1 receptor agonists (GLP-1RAs) on clinical and safety outcomes including glycemic control and cardiometabolic indicators using network meta-analysis. METHODS: MEDLINE, Embase, and Cochrane Library Central Register...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yawen, Liu, Jia, Chen, Xin, Yang, Wenying, Jia, Weiping, Wu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932945/
https://www.ncbi.nlm.nih.gov/pubmed/33582976
http://dx.doi.org/10.1007/s12325-021-01637-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932945/
https://www.ncbi.nlm.nih.gov/pubmed/33582976
http://dx.doi.org/10.1007/s12325-021-01637-6

Ejemplares similares